OBINUTUZUMAB

UNII:	O43472U9X8
Formula:
Preferred Substance Name:	OBINUTUZUMAB

949142-50-1
AFUTUZUMAB
GA101
GA-101
GAZYVA
GAZYVARO
HUMAB CD20
HUMABCD20
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
OBINUTUZUMAB [INN]
OBINUTUZUMAB [JAN]
OBINUTUZUMAB [MART.]
OBINUTUZUMAB [MI]
OBINUTUZUMAB [PURPLE BOOK CDER]
OBINUTUZUMAB [USAN]
OBINUTUZUMAB [VANDF]
OBINUTUZUMAB [WHO-DD]
RG-7159
RO5072759
RO-5072759
RO-5072759 HUMAB CD20

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OBINUTUZUMAB

Synonyms and Mappings

Resources